BBNX
Beta Bionics develops the iLet Bionic Pancreas, an automated insulin delivery system designed for people with type 1 diabetes. The device uses data from Dexcom CGMs or FreeStyle Libre 3 Plus sensors to automate insulin dosing, aiming to reduce user decision-making in diabetes management. The company targets both adults and children, provides resources for healthcare professionals, and emphasizes patient-centered diabetes technology innovation with global reach.
No recent news for this company.
No recent deals for this company.